84 related articles for article (PubMed ID: 4674038)
1. [Symposium: metabolism in neurogical disorders. 1. Parkinsonism. 1-(1). Metabolic disturbance in Parkinsonism].
Tsukada Y; Yamada K; Tsubaki T
Nihon Naika Gakkai Zasshi; 1972 Sep; 61(9):1126-30. PubMed ID: 4674038
[No Abstract] [Full Text] [Related]
2. [Symposium: metabolism in neurological disorders. 1. Parkinsonism. 1-(2). Dopamin metabolism in urine and brain of patients with parkinsonism, with special reference to vitamin B 6 and L-DOPA-treatment].
Kuzuya F; Wakita T; Kawahara H
Nihon Naika Gakkai Zasshi; 1972 Sep; 61(9):1131-5. PubMed ID: 4674039
[No Abstract] [Full Text] [Related]
3. [Effect of MK-486 alone on Parkinsonism; studies on the clinical symptoms and catecholamine concentrations in the blood, urine and cerebrospinal fluid].
Tohgi H; Ogawa M
No To Shinkei; 1977 Feb; 29(2):205-13. PubMed ID: 326277
[No Abstract] [Full Text] [Related]
4. L-dopa metabolism in man (with special reference to parkinsonism).
Sandler M
Sci Basis Med Annu Rev; 1972; ():161-73. PubMed ID: 4564341
[No Abstract] [Full Text] [Related]
5. [Implications of the formulation of m-tyrosine from DOPA for Parkinsonism].
Stoof JC; Koetsier JC
Ned Tijdschr Geneeskd; 1974 Jun; 118(23):900. PubMed ID: 4839449
[No Abstract] [Full Text] [Related]
6. Dopamine and dopamine metabolites in Parkinson's disease-a review.
Barbeau A
Proc Aust Assoc Neurol; 1968; 5(1):95-100. PubMed ID: 4885282
[No Abstract] [Full Text] [Related]
7. Biochemical aspects of experimentally induced parkinsonism.
Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
[No Abstract] [Full Text] [Related]
8. [Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS].
Gründig E; Gerstenbrand F
Wien Klin Wochenschr; 1970 Nov; 82(45):811-6. PubMed ID: 5479021
[No Abstract] [Full Text] [Related]
9. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)].
Nagatsu T
Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927
[No Abstract] [Full Text] [Related]
10. Biosynthesis and metabolism of the catecholamines.
Sandler M
Schweiz Med Wochenschr; 1970 Mar; 100(12):526-31. PubMed ID: 4906882
[No Abstract] [Full Text] [Related]
11. [Symposium: metabolism in neurological disorders. 1. Parkinsonism. Four pedigrees of familial Parkinsonism--mainly on DOPA metabolism].
Uono M; Segawa M; Aoyama M
Nihon Naika Gakkai Zasshi; 1972 Sep; 61(9):1136-8. PubMed ID: 4674040
[No Abstract] [Full Text] [Related]
12. [Diurnal variations of human serum amino acid concentration].
Gründig E; Kollner U; Simanyi M
Acta Med Austriaca; 1978; 5(1):8-11. PubMed ID: 685637
[TBL] [Abstract][Full Text] [Related]
13. Catecholamine-containing grafts in parkinsonism: past and present.
Hoffer BJ; Granholm AC; Stevens JO; Olson L
Clin Res; 1988 Apr; 36(3):189-95. PubMed ID: 3286096
[No Abstract] [Full Text] [Related]
14. [Changes of catecholamine metabolism and symptoms of parkinsonism in rats with manganotoxicosis].
Samoĭlova ZT; Shavolina VA
Gig Tr Prof Zabol; 1974 Apr; 18(4):16-20. PubMed ID: 4845000
[No Abstract] [Full Text] [Related]
15. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.
Murray AM; Weihmueller FB; Marshall JF; Hurtig HI; Gottleib GL; Joyce JN
Ann Neurol; 1995 Mar; 37(3):300-12. PubMed ID: 7695230
[TBL] [Abstract][Full Text] [Related]
16. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
17. Peripheral aromatic L-amino acids decarboxylase inhibitor in Parkinsonism. I. Effect on O-methylated metabolites of L-dopa-2- 14 C.
Messiha FS; Hsu TH; Bianchine JR
J Clin Invest; 1972 Feb; 51(2):452-5. PubMed ID: 5009125
[TBL] [Abstract][Full Text] [Related]
18. [On the problem of the metabolism of dopamine in the brain of patients with parkinsonism].
Travenets IA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1505-7. PubMed ID: 6000312
[No Abstract] [Full Text] [Related]
19. [Catecholamine excretion and treatment of parkinsonism with midantan].
Kandel' EI; Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Sep; 76(9):1323-6. PubMed ID: 1015136
[No Abstract] [Full Text] [Related]
20. The metabolism of brain dopamine in human parkinsonism.
Hornykiewicz O
Riv Patol Nerv Ment; 1970 Oct; 91(5):281-6. PubMed ID: 5525774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
